1) caspase-9
半胱天冬酶-9
1.
Objective To study the apoptotic effect of cadmium chloride on anterior pituitary and adrenal cortex and the relations with caspase-9 signal transduction passway.
目的观察CdCl2作用后腺垂体-肾上腺皮质系统凋亡情况及半胱天冬酶-9的表达变化。
2) caspase-9
半胱天冬蛋白酶-9
1.
Objective To observe the effect of local mild hypothermia on expression of X-linked inhibitor of apoptosis protein(XIAP) and Caspase-9 after rat focal cerebral ischemia reperfusion and to study the mechanism of neuroprotection by mild hypothermia.
目的观察病变侧亚低温对大鼠局灶性脑缺血再灌注后X染色体连锁的凋亡抑制蛋白(X-linked inhibitorof apoptosis protein,XIAP)和半胱天冬蛋白酶-9(Caspase-9)表达的影响,研究亚低温的脑保护机制。
3) Caspase
半胱天冬酶
1.
Triptolide induces apoptosis in myelodysplastic syndromes MUTZ-1 cells through activation of caspases and down-regulation of IAPs;
雷公藤内酯醇下调凋亡抑制蛋白、活化半胱天冬酶诱导骨髓增生异常综合征细胞株细胞凋亡的研究
2.
Effect of Supplement Energy and Nourish Lung Herbs on Drug-Resistance Lung Cancer with Mechanisms of Mitochondrial and Caspase Signal;
益气养肺方干预肺癌化疗耐药的线粒体及半胱天冬酶机制
3.
Purpose: To study whether sesquiterpene lactones(SLs) have the inducible apoptosis effect on human nasopharyngeal carcinoma (NPC) and it s relation with the mechanism of caspase activation, Methods: NPC cell line (CNE1) was treated with parthenolide(PN),the principal active component of SLs.
目的 :探讨半胱天冬酶(caspase)活化途径是否在倍半萜烯内酯(SLs)诱导人鼻咽癌(NPC)细胞凋亡中起作用。
4) caspase-3
半胱天冬酶
1.
This study was purposed to observe the changes of caspase-3 activity during apoptosis of HL-60 cells induced by an iron chelator, DFO (deferoxamine), and to explore the mechanism underlying apoptosis in HL-60 cells.
为了研究铁螯合剂—去铁胺(deferoxamine,DFO)诱导人白血病细胞株HL-60凋亡时半胱天冬酶-3(caspase-3)活性的变化并探讨DFO诱导凋亡的可能机制。
2.
[Objective] This paper was conducted to analyze the activity of Caspase-3 and mRNA translation in the EGCG-induced apoptotic.
[目的]研究绿茶多酚(EGCG)诱导肝癌细胞Hep-G2凋亡过程中半胱天冬酶-3(Caspase-3)蛋白活性与mRNA的变化。
5) caspases
半胱天冬酶
1.
Effect of icariine on cell apoptosis in irradiated mice and its relationship with activity of caspases;
淫羊藿甙对辐照小鼠的抗凋亡作用与半胱天冬酶活性的相关性研究
6) Caspase-9
半胱氨酸天冬氨酸蛋白酶9
1.
The possible mechanism is that rHuEPO activates the PI3K/Akt pathway and shows its antiapoptotic neuroprotective effects regulating the expressions of Caspase-9 and XIAP that are regulating factors of chondriosome apoptosis.
方法采用PTZ点燃大鼠SE模型,将大鼠随机分为A组:正常对照组(生理盐水normal saline NS)、B组:PTZ组(PTZ+NS)、C组:rHuEPO组(PTZ+rHuE-PO)、D组:LY294002组(PTZ+LY294002+rHuEPO)、E组:LY294002溶剂DMSO(二甲基亚砜)对照组(PTZ+DMSO+rHuEPO),检测大鼠行为学和脑电图的改变及HE染色观察海马病理学的改变;用TUNEL方法检测海马神经细胞的凋亡情况;免疫组织化学法观察磷酸化蛋白激酶B、半胱氨酸天冬氨酸蛋白酶9(Caspase-9)、X-连锁凋亡抑制蛋白(XIAP)的表达。
补充资料:半胱氨酸乙酯,半胱乙酯
药物名称:半胱氨酸乙酯
英文名:
别名: 半胱氨酸乙酯,半胱乙酯
适应症: 用于治疗急、慢性支气管炎、肺结核、咽喉炎等症以及手术后咳痰困难者。
用量用法: 口服:每次0.1g,每日3次。气管滴入:0.25g溶于5ml溶液内滴入或雾化吸入。
注意事项: 可有恶心、呕吐、食欲不振等;偶有失眠、头晕、皮疹或使哮喘患者产生支气管痉挛。故哮喘患者慎用;严重肝脏及心脏患者忌用。水溶液放置时能缓缓分解,故应临用前配制。
规格: 片剂:0.1g;粉剂:0.25g、0.5g。
类别:祛痰药
英文名:
别名: 半胱氨酸乙酯,半胱乙酯
适应症: 用于治疗急、慢性支气管炎、肺结核、咽喉炎等症以及手术后咳痰困难者。
用量用法: 口服:每次0.1g,每日3次。气管滴入:0.25g溶于5ml溶液内滴入或雾化吸入。
注意事项: 可有恶心、呕吐、食欲不振等;偶有失眠、头晕、皮疹或使哮喘患者产生支气管痉挛。故哮喘患者慎用;严重肝脏及心脏患者忌用。水溶液放置时能缓缓分解,故应临用前配制。
规格: 片剂:0.1g;粉剂:0.25g、0.5g。
类别:祛痰药
说明:补充资料仅用于学习参考,请勿用于其它任何用途。
参考词条